Researchers at the University of California, Los Angeles (UCLA), in collaboration with pathologists from Hadassah Hebrew ...

In this interview, industry expert Dr. Raj Singh discusses the PathoVerse, a pioneering global digital ecosystem designed to transform pathology through connectivity, AI integration, and collaborative ...

VISTA, Calif., Dec. 9, 2025 /PRNewswire/ -- Leica Biosystems, a Danaher company and a global leader in anatomic pathology solutions, is driving the future of clinical diagnostics with another bold ...

NEW YORK, Dec. 4, 2025 /PRNewswire/ -- PreciseDx, the leading innovator behind PreciseBreast, a novel AI digital pathology test, announces the upcoming presentation of three abstracts that further ...

LigoLab, a leading provider of enterprise laboratory information system (LIS) software and fully integrated laboratory revenue cycle management (lab RCM) solutions, and PathPresenter, a global leader ...

In the most traditional definition of return-on-investment, Sam Terese, former CEO and president of Alverno Laboratories, would say that his company isn’t experiencing a strict apples-to-apples ...

Tempus AI shares were higher after the company said it agreed to buy Paige, an AI company focused on digital pathology, for $81.3 million. The stock was up 8.4% at $83.17 and has more than doubled so ...

As the demand for pathology-based diagnoses rises, particularly with the growth of personalised cancer care, improved workflow efficiency allows pathologists to manage their growing caseloads more ...

Dan Roark, CEO of Gestalt, at the company’s Spokane HQ in February 2024. (GeekWire File Photo / Todd Bishop) Gestalt Diagnotistics, a Spokane, Wash.-based healthcare startup, has raised $7.5 million ...

Antibody-drug conjugates (ADCs) are a novel class of cancer therapeutics comprised of a linker-payload conjugated to a selective monoclonal antibody targeting a tumor-associated antigen (TAA) to ...

Influence of MRIs performed in a 6-week interval on the histopathological detection of prostate cancer with different PIRADS classifications: A real-world data analysis. Five-year follow-up of ...